Anticholinergic News and Research

RSS
Combining tiotropium with olodaterol significantly improves lung function in COPD patients

Combining tiotropium with olodaterol significantly improves lung function in COPD patients

SPIRIVA to mark 10th anniversary with European Respiratory Society Congress

SPIRIVA to mark 10th anniversary with European Respiratory Society Congress

Pristine Solutions acquires Eaton Scientific Systems

Pristine Solutions acquires Eaton Scientific Systems

New data from Boehringer Ingelheim and Pfizer's tiotropium clinical studies on asthma, COPD

New data from Boehringer Ingelheim and Pfizer's tiotropium clinical studies on asthma, COPD

Be alert for arrhythmias in new bronchodilator patients, researchers say

Be alert for arrhythmias in new bronchodilator patients, researchers say

FDA approves Forest Laboratories’ Tudorza Pressair to treat COPD

FDA approves Forest Laboratories’ Tudorza Pressair to treat COPD

IACs may increase risk of arrhythmias in young individuals with asthma

IACs may increase risk of arrhythmias in young individuals with asthma

Astellas' mirabegron for OAB receives FDA advisory committee approval

Astellas' mirabegron for OAB receives FDA advisory committee approval

Positive results from Allergan's BOTOX Phase III trials on idiopathic overactive bladder

Positive results from Allergan's BOTOX Phase III trials on idiopathic overactive bladder

Low-dose anticholinergic drugs do not appear to cause cognitive impairment in dementia patients

Low-dose anticholinergic drugs do not appear to cause cognitive impairment in dementia patients

FDA approves Allergan's BOTOX to treat specific form of urinary incontinence

FDA approves Allergan's BOTOX to treat specific form of urinary incontinence

Antares, Watson enter license deal to commercialize Anturol in the U.S. and Canada

Antares, Watson enter license deal to commercialize Anturol in the U.S. and Canada

Anticholinergic medications linked to risk of cognitive impairment, death in older population

Anticholinergic medications linked to risk of cognitive impairment, death in older population

Anticholinergic drugs might increase risk of cognitive impairment, death in older people

Anticholinergic drugs might increase risk of cognitive impairment, death in older people

Some drug mixtures may be fatal for elderly: study

Some drug mixtures may be fatal for elderly: study

Pearl advances PT003 dual combination drug candidate into Phase 2 studies for treatment of COPD

Pearl advances PT003 dual combination drug candidate into Phase 2 studies for treatment of COPD

FDA accepts Antares Pharma's Anturol NDA for filing, assigns PDUFA date

FDA accepts Antares Pharma's Anturol NDA for filing, assigns PDUFA date

Study demonstrates superiority of Spiriva over salmeterol in reducing risk of exacerbations in COPD

Study demonstrates superiority of Spiriva over salmeterol in reducing risk of exacerbations in COPD

Antares Pharma submits NDA for Anturol Gel in patients with overactive bladder

Antares Pharma submits NDA for Anturol Gel in patients with overactive bladder

Palmetto GBA to cover PTNS therapy for patients with overactive bladder

Palmetto GBA to cover PTNS therapy for patients with overactive bladder

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.